Triomics
Triomics is a generative AI-powered platform that matches patients to clinical trials.
About Triomics
Triomics is a generative AI-powered platform that matches patients to clinical trials. The company advances oncology research and care operations by aiding in accelerating trial enrollment, quality improvement projects, and streamlining healthcare operations, among other functions. It's trusted and validated foundational oncology AI, trained to comprehend health records and medical terminology, underpins this critical mission.
Company Facts
- Headquarters
- San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Funding Stage
- early_stage_venture
- Total Funding
- $15,125,000
- Last Funding Type
- non_equity_assistance
- Last Funding Date
- 2024-07-02
- Website
- triomics.com
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Generative AI, Health Care, Hospital, Oncology
Social Links
Canonical: https://fsome.com/organization/triomics-111921 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.